(BRC) Brady - Ratings and Ratios
Safety Signs, Labels, RFID, Printers, Compliance
BRC EPS (Earnings per Share)
BRC Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 23.7% |
| Value at Risk 5%th | 35.1% |
| Relative Tail Risk | -10.19% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -12.80 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.456 |
| Beta | 0.674 |
| Beta Downside | 0.656 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.98% |
| Mean DD | 5.12% |
| Median DD | 4.78% |
Description: BRC Brady November 08, 2025
Brady Corporation (NYSE:BRC) designs, manufactures, and distributes a broad portfolio of identification and workplace-safety solutions-including safety signs, RFID/barcode scanners, lockout/tagout devices, and healthcare-grade wristbands-serving industrial, healthcare, aerospace, and government customers across the Americas, Europe, Asia, and Australia. The company reaches end-users through a mix of distributors, a direct sales force, and expanding digital channels.
Key metrics from the most recent fiscal year (FY 2023) show revenue of roughly $1.5 billion, an operating margin of 12 % and EPS of $2.30, reflecting steady demand for compliance-driven products amid tightening safety regulations. Growth is being propelled by three sector trends: (1) the global push for traceability and ESG reporting, which fuels demand for RFID and barcode solutions; (2) rising capital-intensive activity in renewable-energy and electric-vehicle manufacturing, driving higher spend on industrial labeling and lockout/tagout equipment; and (3) accelerated digital transformation of safety-compliance workflows, boosting sales of Brady’s software and cloud-based auditing services.
For a deeper quantitative assessment, you may find ValueRay’s proprietary valuation models for BRC useful as a next step in your analysis.
BRC Stock Overview
| Market Cap in USD | 3,544m |
| Sub-Industry | Commercial Printing |
| IPO / Inception | 1984-06-28 |
| Return 12m vs S&P 500 | -7.73% |
| Analyst Rating | 5.0 of 5 |
BRC Dividends
| Dividend Yield | 1.32% |
| Yield on Cost 5y | 2.31% |
| Yield CAGR 5y | 1.97% |
| Payout Consistency | 96.5% |
| Payout Ratio | 21.0% |
BRC Growth Ratios
| CAGR 3y | 17.15% |
| CAGR/Max DD Calmar Ratio | 1.07 |
| CAGR/Mean DD Pain Ratio | 3.35 |
| Current Volume | 224.7k |
| Average Volume | 186.3k |
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (189.3m TTM) > 0 and > 6% of Revenue (6% = 90.8m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA -2.70pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 19.26% (prev 24.98%; Δ -5.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 181.2m <= Net Income 189.3m (YES >=105%, WARN >=100%) |
| Net Debt (-15.8m) to EBITDA (282.5m) ratio: -0.06 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (47.8m) change vs 12m ago -0.59% (target <= -2.0% for YES) |
| Gross Margin 50.27% (prev 51.27%; Δ -1.00pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 93.15% (prev 88.51%; Δ 4.64pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 50.95 (EBITDA TTM 282.5m / Interest Expense TTM 4.75m) >= 6 (WARN >= 3) |
Altman Z'' 6.96
| (A) 0.17 = (Total Current Assets 621.8m - Total Current Liabilities 330.3m) / Total Assets 1.73b |
| (B) 0.76 = Retained Earnings (Balance) 1.32b / Total Assets 1.73b |
| (C) 0.15 = EBIT TTM 241.8m / Avg Total Assets 1.62b |
| (D) 2.26 = Book Value of Equity 1.23b / Total Liabilities 542.0m |
| Total Rating: 6.96 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 77.64
| 1. Piotroski 6.50pt = 1.50 |
| 2. FCF Yield 4.35% = 2.18 |
| 3. FCF Margin 10.15% = 2.54 |
| 4. Debt/Equity 0.13 = 2.49 |
| 5. Debt/Ebitda -0.06 = 2.50 |
| 6. ROIC - WACC (= 7.80)% = 9.75 |
| 7. RoE 16.50% = 1.37 |
| 8. Rev. Trend 85.76% = 6.43 |
| 9. EPS Trend -22.41% = -1.12 |
What is the price of BRC shares?
Over the past week, the price has changed by -3.49%, over one month by -3.08%, over three months by +0.67% and over the past year by +5.70%.
Is Brady a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BRC is around 73.81 USD . This means that BRC is currently overvalued and has a potential downside of 0.96%.
Is BRC a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BRC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 95 | 29.9% |
| Analysts Target Price | 95 | 29.9% |
| ValueRay Target Price | 82.1 | 12.2% |
BRC Fundamental Data Overview November 16, 2025
P/E Trailing = 19.0051
P/E Forward = 13.3511
P/S = 2.3413
P/B = 2.9725
P/EG = 2.5
Beta = 0.69
Revenue TTM = 1.51b USD
EBIT TTM = 241.8m USD
EBITDA TTM = 282.5m USD
Long Term Debt = 99.8m USD (from longTermDebt, last quarter)
Short Term Debt = 15.2m USD (from shortTermDebt, last quarter)
Debt = 158.6m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -15.8m USD (from netDebt column, last quarter)
Enterprise Value = 3.53b USD (3.54b + Debt 158.6m - CCE 174.3m)
Interest Coverage Ratio = 50.95 (Ebit TTM 241.8m / Interest Expense TTM 4.75m)
FCF Yield = 4.35% (FCF TTM 153.6m / Enterprise Value 3.53b)
FCF Margin = 10.15% (FCF TTM 153.6m / Revenue TTM 1.51b)
Net Margin = 12.50% (Net Income TTM 189.3m / Revenue TTM 1.51b)
Gross Margin = 50.27% ((Revenue TTM 1.51b - Cost of Revenue TTM 752.8m) / Revenue TTM)
Gross Margin QoQ = 50.40% (prev 50.98%)
Tobins Q-Ratio = 2.03 (Enterprise Value 3.53b / Total Assets 1.73b)
Interest Expense / Debt = 0.72% (Interest Expense 1.14m / Debt 158.6m)
Taxrate = 17.57% (10.6m / 60.5m)
NOPAT = 199.4m (EBIT 241.8m * (1 - 17.57%))
Current Ratio = 1.88 (Total Current Assets 621.8m / Total Current Liabilities 330.3m)
Debt / Equity = 0.13 (Debt 158.6m / totalStockholderEquity, last quarter 1.19b)
Debt / EBITDA = -0.06 (Net Debt -15.8m / EBITDA 282.5m)
Debt / FCF = -0.10 (Net Debt -15.8m / FCF TTM 153.6m)
Total Stockholder Equity = 1.15b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.91% (Net Income 189.3m / Total Assets 1.73b)
RoE = 16.50% (Net Income TTM 189.3m / Total Stockholder Equity 1.15b)
RoCE = 19.39% (EBIT 241.8m / Capital Employed (Equity 1.15b + L.T.Debt 99.8m))
RoIC = 15.96% (NOPAT 199.4m / Invested Capital 1.25b)
WACC = 8.16% (E(3.54b)/V(3.70b) * Re(8.50%) + D(158.6m)/V(3.70b) * Rd(0.72%) * (1-Tc(0.18)))
Discount Rate = 8.50% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -2.02%
[DCF Debug] Terminal Value 77.84% ; FCFE base≈162.2m ; Y1≈175.8m ; Y5≈218.8m
Fair Price DCF = 80.40 (DCF Value 3.50b / Shares Outstanding 43.6m; 5y FCF grow 9.43% → 3.0% )
EPS Correlation: -22.41 | EPS CAGR: -54.91% | SUE: -4.0 | # QB: 0
Revenue Correlation: 85.76 | Revenue CAGR: 7.87% | SUE: 0.93 | # QB: 1
Additional Sources for BRC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle